12:00 AM
 | 
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Resten-NG: Began Phase I testing

AVI BioPharma Inc. (AVII), Portland, Ore.
Product: Resten-NG
Business: Cardiovascular
Therapeutic category: Antisense...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >